Assessment of myocardial viability

Current Opinion in Cardiology

Volumn 12, Issue 5, 1997, Pages 459-467

  Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; TECHNETIUM 99M; THALLIUM 201;

CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY BYPASS SURGERY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; GLUCOSE TRANSPORT; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MYOCARDIAL HIBERNATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; SYMPTOM;

EID: 0030821788     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199712050-00005     Document Type: Short Survey

References (52)

1. Rahimtoola SH: The hibernating myocardium. Am Heart J 1989, 117:211-221.
2. Vanoverschelde J-LJ, Wijns W, Borgers M, Heyndrickx G, Depré C, Flameng W, Melin JA: Chronic myocardial hibernation in humans: from bedside to bench. Circulation 1997, 95:1961-1971.
3. Hendel RC, Chaudhry FA, Bonow RO: Myocardial viability. Curr Probl Cardiol 1996, 21:145-224.
4. 201TI scintigraphy and low-dose dobutamine echocardiography for the noninvasive assessment of myocardial viability. Circulation 1996, 94:2681-2684.
5. Beller GA: Assessment of myocardial perfusion and metabolism for assessment of myocardial viability. Q J Nucl Med 1996, 40:55-67.
6. McGhie AI, Weyman A: Searching for hibernating myocardium: time to reevaluate investigative strategies? Circulation 1996, 94:2685-2688.
7. Bonow RO: Identification of viable myocardium. Circulation 1996, 94:2674-2680.
8. Iskandrian AS, Heo J, Schelbert HR: Myocardial viability: methods of assessment and clinical relevance. Am Heart J 1996, 32:1226-1235.
9. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA: Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977, 55:294-302.
10. Moore CA, Cannon J, Watson DD, Kaul S, Beller GA: Thallium 201 kinetics in stunned myocardium characterized by severe postischemic systolic dysfunction. Circulation 1990, 81:1622-1632.
11. Sansoy V, Glover DK, Watson DD, Ruiz M, Smith WH, Simanis JP, Beller GA: Comparison of thallium-201 resting redistribution with technetium 99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 1995, 92:994-1004.
12. Dilsizian V, Rocco TP, Freedman NMT, Leon MB, Bonow RO: Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990, 323:141-146.
13. 18F-fluorodeoxyglucose. Circulation 1991, 83:26-37.
14. Ohtani H, Tamaki N, Yonekura Y, Mohiuddin IH, Hirata K, Ban T, Konish J: Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass grafting. Am J Cardiol 1990, 66:394-399.
15. 201TI in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1992, 86:1125-1137.
16. 201TI activity in irreversible defects as a marker of myocardial viability: clinicopathological study. Circulation 1995, 91:1016-1021.
17. 201TI reinjection enhances detection of reversible myocardial hypoperfusion: a randomized, double-blind, parallel, placebo-controlled trial. Circulation 1997, 95:1799-1805.
18. Beller GA: Assessment of myocardial viability. In Clinical Nuclear Cardiology. Philadelphia: WB Saunders; 1995:293-336.
19. 201TI imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993, 87:1630-1641.
20. Perrone-Filardi P, Pace L, Prastaro M, Piscione F, Betocchi S, Squame F, Vezzuto P, Soricelli A, Indolfi C, Salvatore M, Chiariello M: Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995, 91:2556-2565.
21. 99mTc-sestamibi. Circulation 1994, 89:2552-2561.
22. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M: Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997, 96:793-800.
23. Dreyfus GD, Duboc D, Blasco A, Vigoni F, Dubois C, Brodaty D, de Lentdecker P, Bachet J, Goudot B, Guilmet D: Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 1994, 57:1402-1407; discussion 1407-1408.
24. Gioia G, Powers J, Heo J, Iskandrian AS: Prognostic value of rest redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995, 75:759-762.
25. Paolini G, Lucignani G, Zuccari M, Landoni C, Vanoli G, Di Credico G Rossetti C, Mariani MA, Fazio F, Grossi A: Identification and revascularization of hibernating myocardium in angina free patients with left ventricular dysfunction. Eur J Cardiothorac Surg 1994, 8:139-144.
26. 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion. Circulation 1992, 85:1531-1541.
27. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion. Circulation 1993, 87:2033-2042.
28. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA: Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996, 27:1592-1597.
29. Maes AF, Borgers M, Flameng W, Nuyts JL, van de Werf F, Ausma JJ, Sergeant P, Mortelmans LA: Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997, 29:62-68.
30. 99mTc sestamibi in patients undergoing cardiac transplantation: a scintigraphic/pathological study. Circulation 1996, 94:1010-1017.
31. Cuocolo A, Pace L, Ricciardelli B, Chianello M, Trimarco B, Salvatore M: Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile. J Nucl Med 1992, 33:505-511.
32. 18F] fluorodeoxyglucose. Circulation 1994, 89:578-587. [published erratum appears in Circulation 1995, 91:3026.]
33. Maurea S, Cuocolo A, Pace L, Nicolai E, Nappi A, Imbriaco M, Trimarco B, Salvatore M: Left ventricular dysfunction in coronary artery disease: comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging. J Nucl Cardiol 1994, 1:65-71.
34. Sawada SG, Allman KC, Muzik O, Beanlands RS, Wolfe ER Jr, Gross M, Fig L, Schwaiger M. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994, 23:92-98.
35. Soufer R, Dey HM, Ng CK, Zaret BL: Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995, 75:1214-1219.
36. Li ST, Liu XJ, Lu ZL, Shi RF, Zhu XD, Chen WQ, Wu QW, Liu YZ: Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996, 3:457-463.
37. Bisi G, Sciagra R, Santoro GM, Rossi V, Fazzini PF: Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995, 36:1994-2000.
38. Smanio PEP, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA: The value of gating of technetium-99m-sestamibi single-photon emission tomographic (SPECT) imaging. J Am Coll Cardiol, in press.
39. Koplan BA, Beller GA, Ruiz M, Yang JY, Watson DD, Glover DK: Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. J Nucl Med 1996, 37:1398-1402.
40. 201TI in a model of acute coronary reperfusion. Circulation 1996, 94:2605-2613.
41. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, Hirai J-I, Saga T, Yamamoto S, Tonami N: Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201. J Am Coll Cardiol 1997, 29:1226-1233.
42. Schelbert HR: Metabolic imaging to assess myocardial viability. J Nucl Med 1994, 35(suppl):8S-14S.
43. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, et al.: Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994, 73:527-533.
44. Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J: Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995, 92:3436-3444.
45. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM. Schwaiger M: Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992, 20:559-565.
46. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacIntyre WJ, Thomas JD: Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994, 90:2687-2694.
47. 201TI single-photon emission computed tomography. Circulation 1995, 91:2748-2752.
48. Vanoverschelde J-LJ, Gerber BL, D'Hondt AM, De Kock M, Dion R, Wijns W, Melin JA: Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995, 92(suppl II):37-44.
49. Vanoverschelde JL, D'Hondt AM, Marwick T, Gerber BL, De Kock M, Dion R, Wijns W, Melin JA: Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. J Am Coll Cardiol 1996, 28:432-442.
50. 201TI scintigraphy for viability determination. All are cited in this review (Beller, Circulation 1996, 94:2681-2684; McGhie and Weyman, Circulation 1996, 94:2685-2688; and Bonow. Circulation 1996, 94:2674-2680).
51. Nagueh SF, Vaduganathan P, Ali N, Blaustein A, Verani MS, Winters WL Jr, Zoghbi WA: Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997, 29:985-993.
52. Gerber BL, Vanoverschelde JL, Bol A, Michel C, Labar D, Wijns W, Melin JA: Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996, 94:651-659.